m. Provisions and Contingent liabilities
A provision is recognized when an enterprise has a present legal or constructive obligation as a result of past events, and it is probable that an outflow of resources will be required to settle the obligation, in respect of which the amount can be reliably estimated. Provisions are not discounted to its present value and are determined based on best estimate required to settle the obligation at the balance sheet date. These are reviewed at each balance sheet date and adjusted to reflect the current best estimate.
A disclosure for contingent liability is made when there is a possible obligation that arises from the past events and the existence of which will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the Company and that may, but not probable that an outflow of resources would be required to settle the obligation. Where there is a possible obligation or a present obligation in respect of which the likelihood of outflow of resources is remote, no provision or disclosure is made.
(e) Employee Stock option plans ('ESOP')
ESOP 2006 Plan
The ESOP 2006 Plan was introduced by the Company in 2006 under which the Company grants options from time to time to employees of the Company and its subsidiaries. This Plan was approved by the Board of Directors in January 2006 and by the shareholders in February 2006. The Plan complies with Securities and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014 and is administered by the Saksoft Employees Welfare Trust ('the Trust) through the Nomination and Remuneration committee. The Trust purchased the shares of the Company using the proceeds of loans obtained from the Company and administers the allotment of shares to employees and other related matters. The eligible employees exercise the options under the terms of the Plan at an exercise price, which equals the fair value on the date of the grant, until which the shares are held by the Trust.
The Company had allotted 58,24,600 equity shares of Rs.1.00 each to the Trust to give effect to the ESOP Plan. As at the balance sheet date, the employees have exercised 5,00,000 options under this Plan and accordingly, 53,24,600 equity shares of Rs.1.00 each represent shares held by the Trust. During the year no options have been granted or outstanding under this plan. However, out of the 3,66,000 equity shares exercised during the year under ESOP 2009 Plan, 15,000 equity shares were alloted from the shares held by the Trust, based on approval obtained through postal ballot in October 2023. Accordingly, 53,09,600 shares of Rs.1.00 each represent shared held by the Trust.
ESOP 2009 Plan
The ESOP 2009 Plan was introduced by the Company with the consent of the shareholders in 2009 under which the Company grants options from time to time to employees of the Company and its subsidiaries. Further the scheme was amended at the AGM held on 26th September 2014 to increase the exercise period from 5 to 10 years. This Plan complies with the Securities and Exchange Board of India (Share Based Employee Benefits) Regulations, 2014
The plan considers an aggregate of 1,50,00,000 options to be granted and exercised in accordance with the ESOP 2009 plan as approved by the Nomination and Remuneration Committee. The outstanding options available for exercise under the ESOP 2009 as on 31st March 2024 is 45,74,000 options, of which 18,30,000 options being unvested.
During the year, the Board of Directors have allotted 3,66,000 equity shares consequent to the exercise of options by certain eligible employees of the Company who were granted options on 25th May 2015 at grant price of Rs.15.17 per option (1,00,000 equity shares), on 8th July 2014 at a grant price of Rs.9.30 per option (1,00,000 equity shares) and on 26th May 2022 at a grant price of Rs.76.44 per option (1,66,000 equity shares) under ESOP 2009 plan. Subsequent to the exercise, the listing and trading approval was obtained from National Stock Exchange on 27 July 2023 for 47,000 shares , on 21 September 2023 for 68,000 shares ,on 28 September 2023 for 2,06,000 shares , on 15 November 2023 for 30,000 shares. Out of the 3,66,000 equity shares exercised during the year, 15,000 equity shares were alloted from the shares held by the Saksoft Employees Welfare Trust ('the Trust'), based on approval obtained through postal ballot in October 2023. The paid up share capital of the Company after allotment of 3,66,000 equity shares stands at 10,60,41,000 Equity Shares as of 31st March 2024. During the year,3,80,000 options have been granted under this plan at an exercise price of Rs. 232.05 per option.
(g) Dues to Micro and small enterprises
The Company has initiated the process of obtaining confirmation from suppliers who have registered under the Micro, Small and Medium Enterprises Development Act, 2006.
The information required to be disclosed under the Micro, Small And Medium Enterprises Development Act, 2006 ('the MSMED Act”) has been determined to the extent such parties have been identified on the basis of information received from such parties and available with the Company. There are no overdue to parties on account of principal amount and / or interest as disclosed below:
(h) Dividend
The Board of Directors had recommended interim dividend during the financial year 2023-24 amounting to Rs 0.40 per equity share. This has resulted in a cash flow of Rs 42.42 Million.
The Board of Directors at its meeting held on 27th May 2024 had further recommended a final dividend of 40 % (Rs 0.40 per equity share of Rs.1/- face value fully paid up) subject to approval of the shareholders at The Annual General Meeting. The outflow on account of the final dividend is expected to be Rs 42.42 Million.
(i) Disclosure under Ind AS 115
The entire revenue from operations for the year ended 31st March 2024 and 31st March 2023 related to revenue from software services.
Disaggregation of revenue:
Revenue earned by the company is disaggregated by its sources based on geographical location as disclosed in Note 23 (d) to the consolidated financial statements.
Information about contract balances
The company classifies the right to consideration as Trade receivables and unbilled revenue.
Trade receivables are amounts billed to the customer on satisfaction of performance obligation. Unbilled revenue represents revenues in excess of efforts billed on software development and service contracts as at the end of the reporting period and is included as part of Other Financial Assets.
Billing in excess of revenue are classified as unearned revenue. Balances of trade receivables, unbilled revenue and unearned income are available in the relevant Schedules of the financial statements. Trade receivables and unbilled revenue are net of provision in the Balance Sheet.
22 ADDITIONAL NOTES Contd.
Information about performance obligations
Performance obligations estimates are subject to change and are affected by several factors including change in scope of contracts, its termination, foreign currency adjustments and any other items influencing the measurement, collectability and performance of the contract.
Disclosure relating to remaining performance obligation across all live fixed bid price contracts relate to require the aggregate amounts of transaction price yet to be recognized as at the reporting date and expected timelines to recognize these amounts. In view of the fact that all outstanding contracts have an original expected duration for completion of less than a year no disclosure is warranted.
(j) Capital Management
The Company manages its capital to ensure that it will be able to continue as going concerns while maximizing the return to stakeholders through the optimization of the debt and equity balance. The Company's policy is to maintain a strong capital base so as to maintain investors, creditors and market confidence to sustain future development of the business.
Fair Value Measurement Hierarchy
Foreign exchange forward contracts have been measured using Level 2 (Significant observable inputs) - Fair value measurement hierarchy. Balances as at March 31,2024 and March 31,2023 amounts to Rs.1.5 million and (Rs.3.85 million) million respectively. There have been no transfers between Level 1 and Level 2 during the year.
Foreign Exchange Forward Contracts
The Company is exposed to foreign currency fluctuations on foreign currency assets / liabilities and forecast cash flows denominated in foreign currency. The use of derivatives to hedge foreign currency forecast cash flows is governed by the Company's strategy, which provides principles on the use of such forward contracts and currency options consistent with the Company's Risk Management Policy. The counterparty in these derivative instruments is a bank and the Company considers the risks of non-performance by the counterparty as insignificant. The Company has entered into a series of foreign exchange forward contracts that are designated as cash flow hedges. The Company does not use forward covers and currency options for speculative purposes.
22 ADDITIONAL NOTES Contd.
Liquidity Risk:
Liquidity risk is the risk that the Company will not be able to encounter its financial obligations associated with financial liabilities as they become due. The Company manages its liquidity risk by ensuring, as far as possible, to maintain sufficient liquid funds to meet its liabilities on the due date. The Company consistently generates sufficient cash flows from operations (with adequate reserves) and has access to multiple sources of funding (banking facilities and loans from promoter company) to meet the financial obligations and maintain adequate liquidity for use.
The processes and policies related to such risks are overseen by Senior Management.
(l) Financial Risk Management
The Company is exposed to a variety of financial risks; credit risk, liquidity risk and market risk,viz; foreign currency risk and interest rate risk. The Company has a risk management policy to manage & mitigate these risks.
The Company's risk management policy aims to reduce volatility in financial statements and aims to foresee the unpredictability of financial markets and seek to minimize potential adverse effects on its financial performance.
The Board of Directors reviews and agrees policies for managing each of these risks as summarized below Credit risk:
Credit risk is the risk of financial loss to the Company if a customer or counterparty to the financial instrument fails to meet its contractual obligations and arises principally from the Company's receivables from customers and investment securities.
Financial instruments that potentially subject the Company to concentration of credit risk consists of trade receivables, investments, loans, cash and cash equivalents, other balances with banks and other financial assets. The maximum exposure to credit risk is equal to the carrying value of the financial assets. By their nature, all such financial assets involve risks, including the credit risk of non-performance by counterparties.
The Company periodically assesses the credit quality of the counterparties by taking into account their financial position, past experience, ageing of accounts receivables and any other factor determined by individual characteristic of the counterparty.
i rade receivables:
The Company has used a practical expedient by computing the lifetime expected credit loss allowance for trade receivables based on a provision matrix which takes into account historical credit loss experience and adjusted for forward-looking information. The Company's exposure to customers is diversified. The concentration of credit risk is limited due to the fact that the customer base is large and unrelated.
Market risk:
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Such changes in the values of financial instruments may result from changes in the foreign currency exchange rates, interest rates, credit, liquidity and other market changes. The Company's exposure to market risk is primarily on account of foreign currency exchange rate risk.
Foreign Currency Risk:
The fluctuation in foreign currency exchange rates may have potential impact on the Statement of Profit or Loss and Other Comprehensive Income and equity, where any transaction references more than one currency or where assets / liabilities are denominated in a currency other than the functional currency of the Company.
The Company's exchange risk arises from its foreign currency revenues (primarily in U.S. Dollars, British Pound Sterling /Euros and Singapore Dollars). A significant portion of the Company's revenue are in these foreign currencies, while a significant portion of its corresponding costs are in Indian Rupee. As a result, if the value of Indian rupee appreciates relative to these foreign currencies, the Company's revenue measured in Indian Rupee may decrease and vice versa. The exchange rate between the Indian rupee and these foreign currencies has changed substantiallyin recent periods and may continue to fluctuate substantially in the future.
The Company periodically determines its strategy to mitigate foreign currency risk. The Company evaluates the impact of foreign exchange rate fluctuations by assessing its exposure to exchange rate risks. It hedges a part of these risks by using derivative financial instruments in line with its risk management policies.”
The following table presents foreign currency risk from non-derivative financial instruments as at each reporting period:
For and on behalf of the Board of Directors
For R.G.N. Price & Co.,
Chartered Accountants Aditya Krishna Ajit Thomas
Firm Registration No: 002785S Chairman & Managing Director Director
DIN.00031345 DIN.00018691
Mahesh Krishnan Niraj Kumar Ganeriwal Meera Venkatramanan
Partner COO and CFO Company Secretary
Membership No: 206520
Date: May 27, 2024 Place: Chennai
|